Catalyzing
immunotherapy
CatalYm is a pioneer in translating the therapeutic potential of neutralizing GDF-15 into meaningful clinical responses for patients with solid tumors.
CatalYm is a pioneer in translating the therapeutic potential of neutralizing GDF-15 into meaningful clinical responses for patients with solid tumors.